CinCor
is an Ohio-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of cardio-renal and kidney diseases... Read moreCinCor
is an Ohio-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of cardio-renal and kidney diseases... Read more
News
Feb 24, 2023
MarketScreener
CinCor: AstraZeneca closes CinCor buy; Enhertu wins Chinese approval
Feb 24, 2023
MarketScreener
CinCor: CinCor Pharma : Acquisition/Asset Disposal - Form 8-K
Feb 21, 2023
centralcharts
Press Release: CinCor : CinCor Pharma Announces Receipt of Minutes from End-of-Phase 2 Meeting with the U.S. Food and Drug Administration on Planned Phase 3 Program of Baxdrostat
Feb 13, 2023
Owler
CinCor Pharma, Inc.: CinCor's employee count changed from 21 in Jun 2022 to 19 in Sep 2022
Feb 01, 2023
NewsFile
Press Release: CinCor : SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of CinCor Pharma, Inc. (CINC)
Jan 26, 2023
The Business Journals
CinCor: CinCor CEO: acquisition by AstraZeneca was more than a year in the making
Jan 24, 2023
MarketScreener
CinCor: CINCOR PHARMA INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CinCor Pharma, Inc. - CINC
Jan 23, 2023
BioSpace
CinCor: AstraZeneca Begins Tender Offer to Acquire CinCor Pharma, Inc.
Jan 12, 2023
Global Legal Chronicle
CinCor: AstraZeneca's Acquisition of CinCor Pharma
Jan 11, 2023
EMEA STARTUPS
CinCor: AstraZeneca: Acquired CinCor Pharma for 1.8 billion dollars
CinCor Competitors
1
2
3
4
5
6
7
8
9
10